COVID-19 Virus Infection
Showing 1 - 16 of 16
COVID-19 Virus Infection, COVID-19, Coronavirus Disease-19 Trial in Fort Lauderdale, Elkridge (iStatis COVID-19 Ag Rapid Test,
Completed
- COVID-19 Virus Infection
- +4 more
- iStatis COVID-19 Ag Rapid Test
- "COVID-19 RT-PCR Test EUA Number: EUA200011, Company: Laboratory Corporation of America ("Labcorp")
-
Fort Lauderdale, Florida
- +1 more
Aug 23, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial (Famotidine, Celecoxib, Placebo)
Not yet recruiting
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
- (no location specified)
Aug 15, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,
Active, not recruiting
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Miami, FloridaUS02-04: Integrated Health Solutions
Aug 15, 2022
COVID-19 Virus Infection, Ovarian Function Insufficiency, Fertility Disorders Trial in Istanbul (sars cov 2 biontec vaccine)
Enrolling by invitation
- COVID-19 Virus Infection
- +3 more
- sars cov 2 biontec vaccine
-
Istanbul, Gaziosmanpaşa, TurkeyGaziosmanpasa Training and Research Hospital
Aug 3, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in Diagnosis
Completed
- 2019 Novel Coronavirus Disease
- +8 more
- Diagnostic Test: Diagnostic Software as Medical Device
-
Sunrise, FloridaSunrise Research Institute
Jul 19, 2022
COVID-19 Virus Infection Trial in Salvador (LCLT : 68% elemental L-carnitine and 32 % Tartric acid, Placebo)
Completed
- COVID-19 Virus Infection
- LCLT : 68% elemental L-carnitine and 32 % Tartric acid
- Placebo
-
Salvador, Bahia, BrazilSenai Cimatec
Jun 30, 2022
SafeTy and Efficacy of Preventative CoVID Vaccines
Active, not recruiting
- COVID-19 Virus Infection
- Vaccine Response
- mRNA Vaccines or Viral vector-based vaccines for COVID
-
Toronto, Ontario, CanadaUniversity Health Network
May 19, 2022
COVID-19, Infections, COVID-19 Virus Infection Trial in Fayoum (reusable respirators)
Completed
- COVID-19
- +2 more
- reusable respirators
-
Fayoum, EgyptFaculty of Dentistry, Fayoum university
May 11, 2022
Covid-19 Vaccine Response in Heart Transplant Recipients
Not yet recruiting
- Heart Transplantation
- +2 more
- Biospecimen Collection
- +2 more
- (no location specified)
Mar 7, 2022
COVID-19 Virus Infection Trial in Soweto, Durban, George (Telacebec, COVID-19 Standard of care)
Terminated
- COVID-19 Virus Infection
- Telacebec
- COVID-19 Standard of care
-
Soweto, Gauteng, South Africa
- +2 more
Feb 12, 2022
COVID-19 Virus Infection Trial in Ciudad Autónoma de Buenos Aires (Inactivated SARS-CoV-2 vaccine (Vero cell), Placebo/Aluminum
Completed
- COVID-19 Virus Infection
- Inactivated SARS-CoV-2 vaccine (Vero cell)
- Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- +3 more
Jan 11, 2022
COVID-19 Virus Infection, Cytokine Storm, Corticosteroid Trial (Methylprednisolone, Tocilizumab)
Withdrawn
- COVID-19 Virus Infection
- +3 more
- (no location specified)
Nov 22, 2021
Risk Factors for COVID-19 Mortality
Terminated
- COVID-19 Virus Infection
- +2 more
-
Piacenza, Emilia-Romagna, ItalyAzienda USL di Piacenza
Nov 7, 2021
2019 Novel Coronavirus Infection, COVID-19 Virus Infection, SARS Coronavirus 2 Infection Trial in Tucson (USB002, Placebo)
Recruiting
- 2019 Novel Coronavirus Infection
- +5 more
- USB002
- Placebo
-
Tucson, ArizonaThe University of Arizona Health Sciences Center/ Banner Healthc
Aug 2, 2021
COVID-19 Virus Infection Trial in Milano (Interferon-ß-1a, Standard of Care (SOC))
Terminated
- COVID-19 Virus Infection
- Interferon-ß-1a
- Standard of Care (SOC)
-
Milano, ItalyIRCCS Ospedale San Raffaele
Apr 28, 2021